DDX3X and Stress Granules: Emerging Players in Cancer and Drug Resistance

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Biology

Background:

• The DEAD (Asp-Glu-Ala-Asp)-box helicase 3 X-linked (DDX3X) protein is involved in mRNA metabolism, stress granule formation, signal transduction, and cell cycle regulation.
• DDX3X dysfunction is linked to various cancers, including brain, leukemia, prostate, and head and neck cancers.
• Stress granule formation is increasingly associated with cancer drug resistance and poor prognosis.

Purpose of the Study:

• To review the biological functions of DDX3X.
• To summarize DDX3X's role in stress granule formation and cellular stress adaptation.
• To discuss the implications of DDX3X and stress granules in cancer drug resistance and explore DDX3X inhibitors for cancer therapy.

Main Methods:

• Literature review of DDX3X functions.
• Analysis of DDX3X's role in mRNA metabolism, signal transduction, and cell cycle.
• Summary of DDX3X's contribution to stress granule formation and cellular stress response.
• Discussion of DDX3X, stress granules, and cancer drug resistance, including current inhibitor research.

Main Results:

• DDX3X plays a multifaceted role in fundamental cellular processes.
• DDX3X is implicated in stress granule formation, a mechanism linked to cancer progression.
• The interplay between DDX3X, stress granules, and drug resistance is a key area for therapeutic development.

Conclusions:

• DDX3X is a critical regulator of mRNA metabolism and cellular stress responses.
• Targeting DDX3X presents a potential strategy to combat cancer drug resistance.
• Further research into DDX3X inhibitors is warranted for advancing cancer treatment.